Search Results 1041-1050 of 17956 for Lupus

1. Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet - Mayo Clinic

   ... lupus that is stable and without GI involvement, well controlled autoimmune thyroid disease, well controlled type 1 diabetes or proton pump inhibitor ...

2. Collaboration that changes lives - Mayo Clinic News Network

   Lupus rates increasing, communities of color especially vulnerable. Related Articles. (VIDEO) Rare transplant turns strangers into friends featured image.

3. Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression - Mayo Clinic

   Clinical and histologic evidence of IgA predominant Lupus nephritis; Patients with greater than 50% glomerular senescence or cortical scarring on renal ...

4. Mayo Clinic Q and A: Various treatments available for uterine fibroids that cause symptoms

   — Shannon Laughlin-Tommaso M.D., Obstetrics and Gynecology, Mayo Clinic, Rochester, Minn. Lupus: Your body's immune system attacks your own tissues and organs.

5. Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis - Mayo Clinic

   -A history or presence of disease that can mimic MS symptoms, such as, but not limited to neuromyelitis optica spectrum disorder, systemic lupus erythematosus, ...

6. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

   ... lupus erythematosus, autoimmune vasculitis [e.g. Wegener's granulomatosis]); CNS or motor neuropathy considered of autoimmune origin [e.g., Guillain-Barre ...

7. Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   ... lupus anti-coagulant has been confirmed; Presence of biopsiable disease and willingness to undergo pre-treatment biopsy; Women of child-bearing potential and ...

8. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

   Subject has active, known or suspected autoimmune disease, including systemic lupus erythematodes, Hashimotos thyroiditis, scleroderma, polyarteritis nodosa or ...

9. Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) with Avelumab in Muscle Invasive Bladder Cancer - Mayo Clinic

   Known diagnosis of any condition (i.e. post-hematopoietic or organ transplant, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, ...

10. Patient information - Transplant Immunology Program - Mayo Clinic Research

    Mayo Clinic offers a wide range of clinical treatments and services for people with transplant needs and concerns. Make an appointment today.